GYNZONE ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.5% 6.5% 1.0% 1.0% 3.1%  
Credit score (0-100)  64 36 86 88 55  
Credit rating  BBB BBB A A BBB  
Credit limit (kDKK)  0.0 0.0 371.0 476.5 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  3,013 1,630 4,204 4,591 3,703  
EBITDA  637 -365 2,439 2,156 290  
EBIT  130 -1,127 1,558 1,219 -778  
Pre-tax profit (PTP)  130.1 -1,120.5 1,545.9 1,200.0 -795.7  
Net earnings  100.8 -807.8 1,242.4 924.5 -632.5  
Pre-tax profit without non-rec. items  130 -1,120 1,546 1,200 -796  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  21.1 19.6 7.4 1.7 0.0  
Shareholders equity total  1,875 2,270 3,512 4,437 3,804  
Interest-bearing liabilities  131 0.0 0.0 0.0 36.7  
Balance sheet total (assets)  3,272 3,824 5,158 6,685 6,157  

Net Debt  131 -93.8 -1,847 -3,207 -2,228  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  3,013 1,630 4,204 4,591 3,703  
Gross profit growth  87.4% -45.9% 157.9% 9.2% -19.3%  
Employees  5 4 2 3 5  
Employee growth %  25.0% -20.0% -50.0% 50.0% 66.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,272 3,824 5,158 6,685 6,157  
Balance sheet change%  48.7% 16.9% 34.9% 29.6% -7.9%  
Added value  636.6 -364.5 2,438.8 2,099.7 290.5  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  841 -555 -874 -805 -931  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 -1.0 1.0 2.0 -1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  4.3% -69.1% 37.1% 26.6% -21.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.7% -31.5% 34.9% 20.8% -11.9%  
ROI %  6.0% -43.6% 46.5% 26.9% -16.3%  
ROE %  5.5% -39.0% 43.0% 23.3% -15.4%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  57.3% 59.4% 68.1% 66.4% 61.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  20.6% 25.7% -75.7% -148.8% -767.1%  
Gearing %  7.0% 0.0% 0.0% 0.0% 1.0%  
Net interest  0 0 0 0 0  
Financing costs %  -0.8% 6.3% 0.0% 0.0% 172.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.7 0.9 2.2 2.3 1.6  
Current Ratio  0.7 0.9 2.2 2.3 1.6  
Cash and cash equivalent  0.0 93.8 1,846.8 3,207.2 2,264.9  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -254.0 -171.5 1,284.3 2,112.3 1,179.0  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  127 -91 1,219 700 58  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  127 -91 1,219 719 58  
EBIT / employee  26 -282 779 406 -156  
Net earnings / employee  20 -202 621 308 -127